MedPath

HaemoDialysis Interventions to REduce Multi-Organ Dysfunction and Effect on Quality of Life Assessed by MRI Scanning

Not Applicable
Completed
Conditions
Cardiovascular Diseases
Congenital Disorders
Renal Failure
Interventions
Other: HD, Magnetic Resonance Imaging (MRI) scans
Registration Number
NCT03280901
Lead Sponsor
Fresenius Medical Care Deutschland GmbH
Brief Summary

The purpose of this study is to characterise in detail cardiac, cerebral and renal structure, function and perfusion in patients on haemodialysis (HD) using magnetic imaging techniques. The effects of a standard prescription haemodialysis (dialysate temperature 37 C) will be compared to a thermocontrolled (or isothermic) haemodialysis prescription to ascertain if thermocontrolled HD provides a protective effect on organ perfusion and circulatory stress when compared to conventional haemodialysis. The BTM (blood temperature monitor, Fresenius) offers a way to overcome this to regulate thermal balance during dialysis and achieve a neutral thermal balance (isothermic) over the dialysis session. Other dialysis parameters will be standardised between treatment arms using blood volume monitoring (BVM) and clinical assessments.

Detailed Description

The purpose of this study is to characterise in detail cardiac, cerebral and renal structure, function and perfusion in patients on haemodialysis (HD) using magnetic imaging techniques. The Primary objectives are to investigate the difference in cardiac perfusion, structure and function between standard HD and thermocontrolled HD using magnetic imaging techniques, to observe the the changes in renal perfusion and oxygenation within one dialysis session and the changes to cerebral perfusion within one dialysis session.

The secondary objectives are to investigate the difference in cerebral perfusion, structure, oedema and function between standard HD and thermocontrolled HD, the difference in renal perfusion and oxygenation between standard HD and thermocontrolled HD and the differences in visual acuity and cognitive assessment across a dialysis session and over a dialysis treatment course.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
17
Inclusion Criteria
  • Age 18-80, male and female
  • Informed consent signed and dated by study patient and investigator/authorised physician
  • Average (4 weeks prior to recruitment) Ultrafiltration volumes ≥ 0.5 litres/ dialysis session
  • Receiving dialysis via an arteriovenous fistula
  • Must be able to follow simple instruction in English (on safety grounds for MRI scans) and be able to understand the nature and requirements of the study
  • Stable dialysis prescription
  • CKD5 (Chronic kidney disease) patients having renal replacement therapy with haemodialysis/ haemodiafiltration (>90 days)
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Standard HDHD, Magnetic Resonance Imaging (MRI) scansHD with constant temperature of 37°C, MRI scans of the heart, kidneys and brain during HD sessions
Thermocontrolled HDHD, Magnetic Resonance Imaging (MRI) scansHD applying the Blood Temperature Monitor (BTM), MRI scans of the heart, kidneys and brain during HD sessions
Primary Outcome Measures
NameTimeMethod
Change in cerebral perfusion during standard HD and thermocontrolled HDafter 2 and 4 weeks after randomisation

Change in cerebral perfusion during standard HD and thermocontrolled HD using ASL

Change in cardiac output during standard HD and thermocontrolled HDafter 2 and 4 weeks after randomisation

Change in cardiac output during standard HD and thermocontrolled HD using Phase Contrast Magnetic Resonance Imaging (PC-MRI)

Change in renal perfusion during standard HD and thermocontrolled HDafter 2 and 4 weeks after randomisation

Change in renal perfusion using Arterial Spin Labelling (ASL) and renal artery flow using PC-MRI

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Nottingham, Division of Medical Sciences and Graduate Entry Medicine

🇬🇧

Nottingham, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath